JW saw the highest growth of 1.79% in patent filings and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.79% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of JW’s patent filings and grants. Buy the databook here.
JW has been focused on protecting inventions in South Korea(KR) with six publications in Q2 2024
The South Korea(KR) Patent Office dominates the patent filings and grants with nearly 38% filings and 100% grants. The South Korea(KR), World Intellectual Property Organization(WIPO), United States(US), and European Patent Office(EPO) patent Office are among the top ten patent offices where JW is filings its patents. Among the top granted patent authorities, JW has 100% of its grants in South Korea(KR).
Eli Lilly and Co could be the strongest competitor for JW
Pruritus related patents lead JW portfolio followed by atopic dermatitis (atopic eczema), and angioedema
JW has highest number of patents in pruritus followed by atopic dermatitis (atopic eczema), angioedema, cosmetics & toiletries, and hair loss treatments.
For comprehensive analysis of JW's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.